GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

Caliber Imaging & Diagnostics LCDX · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 28 Oct 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2013

Revenue

$3.3m

FY2013FY2013

Net income

−$5.5m

FY2013FY2013

Free cash flow

−$4.9m

FY2013FY2013

Shareholders' equity

−$12.5m

FY2013FY2013

Income statement

Fiscal years

FY2013
Revenue$3.3m
Gross profit$653,856
Research and development$1.5m
Operating income−$4.9m
Net income−$5.5m
Diluted earnings per share-0.65

Balance sheet

At each fiscal year end

FY2013
Total assets$2.4m
Cash and short-term investments$786,509
Total liabilities$14.9m
Debt$11.8m
Shareholders' equity−$12.5m
Shares outstanding8m

Cash flow

Fiscal years

FY2013
Cash from operations−$4.8m
Capital spending−$27,652
Free cash flow−$4.9m

Latest quarters

By quarter end

Mar 2014Dec 2013Sept 2013Jun 2013Mar 2013Dec 2012Sept 2012Jun 2012
Revenue$858,138$1.1m$691,732$515,814$1.1m$1.1m$413,509$571,749
Gross profit$142,359$316,441$94,932−$67,730$310,213$125,872−$231,110−$39,900
Operating income−$1.6m−$1.1m−$1.6m−$1.2m−$933,589−$978,859−$2.9m−$2.7m
Net income−$1.8m−$1.3m−$1.9m−$1.3m−$1.1m−$1.0m−$3.1m−$2.3m
Diluted earnings per share-0.22-0.15-0.22-0.15-0.13-0.13-0.38-0.29
Cash from operations—−$1.0m−$1.0m−$1.0m——−$3.0m−$1.0m
Total assets$2.2m$2.4m$4.3m$4.9m$1.7m$2.6m$2.8m$1.2m
Cash and short-term investments$229,537$786,509$2.4m$3.9m$333,378$926,447$1.7m$145,735
Debt$5.1m$5.0m$23,500$54,833$7.1m$7.1m$7.1m$2.8m
Shareholders' equity−$14.2m−$12.5m−$10.6m−$9.9m−$8.7m−$7.7m−$7.3m−$5.1m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue8.3%——
Operating income10.9%——
Net income8.4%——

Average margins

Over each period

1 year3 years5 years10 years
Gross margin11.9%32.2%——

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return1100%300%64700%-98%-42%525%-48%278%-27%135%

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.